Cytodyn Inc (CYDY)

[Amatuer17]

See this answer from tony

CytoDyn's (CYDY) CEO Nader Pourhassan Hosts Investment Community Conference Call (Transcript) $CYDY
http://www.seekingalpha.com/article/4063244


"Anthony Caracciolo

I guess the right answer to that is we have not been putting a lot of pressure on the sites to enroll the monotherapy patients as quickly as they could, because many of the sites are the same sites that are enrolling the combination trial and quite frankly are looking for salvage patients has been challenging. If it weren’t, we would have reached our enrollment point by the end of the first quarter. So, what we have seen in enrollment is particularly in the same sites, there are many patients out there that are willing to try the monotherapy regimen. And I suspect that once we engage and put a full-court press on to the enrollment of the 300 patients will find that it will be re....."